CanVECTOR Events

February 6, 2024 - 2:00-3:00pm (ET)

Featuring:

• Thrombosis Perspective: Mark Crowther, MD, LLM - McMaster University
• Rheumatology Perspective: Antonio Cabral, MD - University of Ottawa

Learning Objectives:

1. Understand the Key Changes in the New Diagnostic Criteria: Gain a comprehensive understanding of the significant modifications and updates in the new diagnostic criteria for antiphospholipid antibody syndrome;
2. Analyze the Rationale Behind the Updates: Explore the scientific and clinical reasoning that led to the changes in the diagnostic criteria, including insights into the methodologies and evidence that supported these revisions;
3. Compare and Contrast with Previous Criteria: Compare the new diagnostic criteria and the previous standards, highlighting the advancements in understanding and diagnosis of antiphospholipid antibody syndrome;
4. Implications for Clinical Practice: Examine the practical implications of these new criteria on clinical practice, including how they will affect the diagnosis process, patient management, and potential challenges in implementation.